Nebius at $235: Strong Demand, but Financing Structure Raises Execution Risk

What happened

Nebius has surged 181% this year on AI compute demand, a blockbuster Meta deal, and a $37 billion backlog, but new scrutiny of its financing structure reveals how much must go right for current shareholders. The DeepValue master report rates the stock WAIT with attractive entry at $190 and trim above $280, implying no margin of safety at $235 given extreme capex intensity and reliance on large convertibles. Q2 revenue reached $582.3 million with 50% AI-cloud EBITDA margin, yet capital needs remain enormous, including a $5.0 billion convert in August on top of prior dilutive issuances. Both the article and master report emphasize that near-term valuation hinges on successful October price increases, on-time tranche activation, and a shift toward prepayments and secured debt rather than further dilution. The next 6-9 months are pivotal, with Q3/Q4 disclosures providing the first hard evidence of pricing acceptance and execution quality.

Implication

The stock already prices in flawless execution of backlog conversion and sustained scarcity pricing, leaving little room for error. Key downside risks include service credits or tranche terminations under hyperscaler contracts, power or deployment delays, and further large convertible issuance that dilutes per-share value. Near-term catalysts are Q3/Q4 updates on realized ACV per MW after the October 1 price increase and on late-2026 capacity activation. Position sizing should reflect execution volatility; consider trimming above $280 and only adding near $190 with a 3-6 month reassessment window. Monitoring should focus on funding mix (prepayments, secured debt, partner capital vs. new converts) and any signs of pricing power erosion as industry supply expands.

Thesis delta

The investment thesis remains WAIT and conviction is unchanged at 3.5, but the news reinforces that financing risk is even more central than previously emphasized. Previously the focus was on scarcity pricing and execution; now the capital structure itself—especially the heavy reliance on convertibles—appears to be a larger overhang on per-share value. No rating change is warranted, but the burden of proof shifts further to management demonstrating non-dilutive funding and delivery discipline before any upward re-rating.